Antifungal drugs and rational use of antifungals in treating invasive aspergillosis: the role of the hospital pharmacist. (Q36110845)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Antifungal drugs and rational use of antifungals in treating invasive aspergillosis: the role of the hospital pharmacist (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

main subject

aspergillosis

0 references

invasive aspergillosis

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Tiene G M Bauters

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Franky M A Buyle

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Hugo Robays

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

English

0 references

publication date

1 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Pharmacy

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

31-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications

11 January 2020

cites work

1 reference

12 December 2020

Echinocandins and pneumocandins--a new antifungal class with a novel mode of action

1 reference

12 December 2020

Current and emerging azole antifungal agents

1 reference

12 December 2020

Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study

1 reference

12 December 2020

Antifungal chemotherapy: advances and perspectives.

1 reference

12 December 2020

Intravenous to oral (iv:po) anti-infective conversion therapy

1 reference

12 December 2020

Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections.

1 reference

12 December 2020

Echinocandins: a new class of antifungal

1 reference

12 December 2020

Current role of therapy with amphotericin B

1 reference

12 December 2020

Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp

1 reference

12 December 2020

Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study

1 reference

12 December 2020

A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection

1 reference

12 December 2020

Quality indicators for antibiotic control programmes

1 reference

12 December 2020

The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy

1 reference

12 December 2020

Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards

1 reference

12 December 2020

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.

1 reference

12 December 2020

Sequential antimicrobial therapy--the role of quinolones

1 reference

12 December 2020

Evaluation of human albumin use in a university hospital in Belgium

1 reference

12 December 2020

Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units

1 reference

12 December 2020

In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model

1 reference

12 December 2020

Antifungal agents: mechanisms of action

1 reference

12 December 2020

Prevention and treatment of fungal infections in bone marrow transplantation.

1 reference

12 December 2020

10.1007/S11096-004-1735-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15861932%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference